.png)
Mental Health
4
min read
Rethinking Depression: Are We Targeting the Right Neurotransmitters?
The article argues that traditional antidepressants targeting serotonin may overlook the root of depression, and suggests that newer treatments enhancing glutamate signaling—like Auvelity—may offer faster, more profound relief by promoting neuroplasticity and addressing the brain’s adaptability, not just its chemistry.
